中国快讯 (China Crunch) 为中国读者提供及时的加密新闻、市场洞察和监管动态。
China Biotech News: Beijing’s Drive Amid US Decoupling
China biotech news on Beijing’s push to pair chip self-reliance with biotech scale, reshaping trials, devices and US-China cooperation in 2024.
Hong Kong leads world-first robotic liver transplant
Hong Kong surgeons reportedly completed a world-first robotic liver transplant from a living donor, raising questions about minimally invasive benefits, training, and oversight.
Akeso lung cancer drug trial boosts hopes for US$20b market
Akeso lung cancer drug trial results are cautiously boosting optimism for a US$20b market as investors track data quality, timelines, and next regulatory steps.
Hong Kong Tests GLP-1 Drugs for Stroke Recovery
Hong Kong teams are testing GLP-1 weight-loss drugs for stroke treatment, tracking neurological recovery signals, trial design, and market impact today.
Tongji University disciplines cancer researcher Wang
China biotech faces scrutiny after Tongji University disciplined cancer researcher Wang Ping for academic misconduct, prompting calls for tighter oversight.
Biotech investors move upstream in China as competition intensifies for early stage scientific assets
Global competition for China’s biotechnology innovations is entering a more aggressive phase as venture capital firms increasingly shift their focus toward early stage scientific research rather than waiting for assets to reach commercialization. Investors, particularly from the United States, are embedding themselves directly
CK Life Sciences accelerates China entry for cancer vaccine pipeline through fast track clinical strategy
Hong Kong based CK Life Sciences is preparing to advance its cancer vaccine pipeline into mainland China using a faster clinical development pathway as the country expands support for early stage drug innovation. Backed by the business empire of Li Ka-shing, the company
Chinese biotech firm deploys AI chromosome testing to accelerate IVF procedures and tap rising fertility demand
Chinese biotechnology company Hangzhou Diagens Biotechnology is expanding the use of artificial intelligence driven chromosome testing to improve efficiency in in vitro fertilisation and strengthen its commercial growth strategy. The initiative comes as China faces declining birth rates and increasing demand for assisted
China drugmakers race into weight loss market as semaglutide patent expiry opens door to competition
China’s pharmaceutical sector is rapidly moving into the global weight loss drug race after the expiration of Novo Nordisk’s semaglutide patent in the country, unlocking a major commercial opportunity for domestic developers. The shift comes as demand for obesity treatments surges worldwide and
US advances hybrid and GMO wheat research to revive declining crop economics
US researchers and agritech companies are intensifying efforts to revive the struggling wheat sector by developing hybrid and genetically modified seeds designed to boost yields and improve resilience against climate stress. Scientists are experimenting with advanced genetic traits, including drought resistance, as the
Advertisement
